Ipamorelin 5 mg

Ipamorelin 5 mg — the selective secretagogue in growth hormone research
Among growth hormone secretagogues, Ipamorelin is the one prized for what it does not do. Its selectivity is the reason it appears again and again as a clean experimental probe.

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide and a ghrelin receptor (GHS-R1a) agonist. What distinguishes it within the secretagogue class is specificity: research literature consistently describes it as producing growth hormone release with minimal cross-stimulation of cortisol, prolactin and other pituitary outputs seen with earlier, less selective GHRPs. For researchers, that clean profile means an experimental signal less contaminated by confounding hormonal noise — an unusually valuable property when the question being asked is specifically about the GH axis.

Research interest

• GHS-R1a receptor pharmacology — studied as a selective agonist probe for the ghrelin receptor.
• Selective GH release — of interest to researchers seeking secretagogue stimulation without broad pituitary activation.
• Recovery and tissue-turnover models — investigated in preclinical contexts concerned with GH-mediated repair signalling.
• Synergy studies — commonly paired with GHRH analogues in research examining whether the two pathways combine additively or synergistically.
• Comparative secretagogue profiling — used as a selectivity benchmark against GHRP-2, GHRP-6 and related compounds.

As a short pentapeptide, Ipamorelin is straightforward to synthesise but equally straightforward to degrade through poor handling. Sequence-verified, batch-tested material is the baseline requirement for any receptor-binding or signalling work where selectivity itself is the variable under study.

Specifications

• Content: 5 mg of active substance per vial
• Form: Lyophilised powder (vial)
• Purity: Pharmaceutical-grade, batch-tested and lot-traceable
• Presentation: Sealed, tamper-evident single vial
• Storage: -20 °C sealed; 2-8 °C short-term

Handling & storage

Lyophilised material is best held at -20 °C in the sealed, unopened vial. Refrigeration at 2-8 °C is acceptable for short-term handling. Protect from light, humidity and repeated freeze-thaw exposure. Keep the lyophilised powder sealed, dry and frozen for extended storage. Allow the vial to warm before opening to avoid condensation. Reconstitute only within the laboratory's validated procedure using a suitable sterile diluent, then refrigerate, protect from light and minimise freeze-thaw cycling.

Why source it here

• Purity you can document — batch-tested material with traceable lot identification.
• Direct European supply — authentic, sealed vials handled to a strict cold-chain-aware standard.
• No compromise on consistency — controlled sourcing keeps material comparable between orders.
• Rapid discreet dispatch — tracked EU shipping in plain packaging.

For research purposes only. Not a medicinal product. Not for human or veterinary consumption. Intended for qualified laboratory research use only. No statement on this page is a medical claim, and no administration, dosing or protocol guidance is offered or implied.

Related: Peptides · MOTS-c 10 mg · Genadorelin Acetate 2 mg · CJC-1295 no DAC 5 mg